Pulmonx Corp
NASDAQ:LUNG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pulmonx Corp
NASDAQ:LUNG
|
US |
|
F
|
Fabrinet
F:FAN
|
KY |
|
S
|
Sumitomo Metal Mining Co Ltd
DUS:S19
|
JP |
|
Mersen SA
F:CBE
|
FR |
|
B
|
Brockman Mining Ltd
ASX:BCK
|
HK |
Intrinsic Value
Is LUNG undervalued or overvalued?
See the intrinsic value estimate for Pulmonx Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
LUNG looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with LUNG’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Pulmonx Does
Pulmonx makes medical devices for people with severe emphysema, a form of COPD that makes it hard to breathe. Its main product is the Zephyr Valve, a tiny implant placed through a bronchoscope to block off badly damaged parts of the lung so healthier areas can work better. The company also sells the Chartis system, which doctors use to test whether a patient is likely to benefit from the valve treatment.
- Headquarters
- United States of America US
- Employees
- 296
- IPO date
- Oct 1, 2020
Earnings Waterfall
Pulmonx Corp
The intrinsic value for Pulmonx Corp (LUNG) under the Base Case is hidden USD.
Compared with the current market price of 1.88 USD, the stock appears hidden.